Peptides
Oxytocin
Also called Oxytocin
Oxytocin gets attention as a “bonding hormone” and possible libido aid. A nasal-spray trial in women did not outperform placebo for sexual dysfunction. Its established medical use is different: supervised labor and postpartum care.
Dosage & duration
Muin trial in women with sexual dysfunction; intranasal research only.
2015 randomized crossover study
Published example · product-specific- Dose
- 32 IU intranasally
- How often
- Before intercourse, within 50 minutes
- How long
- 8 weeks per treatment; 2-week washout
This was not shown superior to placebo. Nasal and injected doses are not interchangeable.
Sources: 2
The practical difference
Libido research and obstetric care are different uses
The “bonding hormone” nickname is not a treatment result.
| Compare | Nasal sexual-function research | PITOCIN medical care |
|---|---|---|
| Question | Can it improve sexual function? | Medically indicated labor and postpartum care |
| What the source shows | One trial in women found no advantage over placebo | Established obstetric uses under medical supervision |
| Route | Nasal spray in the trial | Injection or infusion according to the indication |
Why people are curious
The appeal is feeling closer to a partner or improving sexual experience. That nickname is more straightforward than the evidence: a hormone involved in social behavior is not a reliable way to create connection.
What the libido trial found
Women used nasal oxytocin or placebo before intercourse in an eight-week crossover study. Sexual-function measures improved in both groups, without a significant treatment advantage. The dose below describes that experiment, not an established wellness routine.
Nasal spray is not an injection equivalent
Obstetric oxytocin is a medically monitored drug with effects on the uterus. Its injection label does not justify a home libido injection or a conversion from nasal IU to injected amounts.
Model details: Oxytocin · relative timing
Compare timing and buildup for this compound. The values are not blood concentrations or a measure of strength.
Shows a relative timing scenario; absolute blood concentrations are not calibrated.
Timing assumptions and sources
Historical 4.32 min is an illustrative selection inside the label plasma range of 1–6 min; it is not a study mean. Pregnancy and lactation change clearance.
One 1 mg input peaks at 1 relative unit after a single dose. Other amounts scale proportionally; overlapping doses add when accumulation is on. Different compounds use separate relative scales.
- Timing half-life used
- 0.072 hours
- Absorption half-life assumed
- 0.018 hours
- Reference amount for the relative scale
- 1 mg
- Absorption half-life is assumed to be one quarter of the slower timescale (0.018 h); it is not a measured absorption parameter.
- A single 1-unit input has a peak of 1 relative unit; scaling and repeated-dose addition are mathematical assumptions. This normalization is independent of the example dose.
- Do not infer an IU-to-mass conversion.
- The assumed 10% availability is not a measured product value.
- Intranasal central delivery and peripheral plasma exposure are not interchangeable.
- PITOCIN label, Clinical Pharmacology
PITOCIN is an IV infusion/IM activity-unit product. Plasma half-life is 1–6 min; the 2–3 h uterine response after IM dosing is a duration of effect, not plasma half-life.
oxytocin-relative-timing-2026-10 · version 1
Common questions
Is oxytocin a proven libido booster?
Not from the cited nasal-spray trial: treatment did not outperform placebo.
Can a nasal dose be used as an injection dose?
No. The formulations and exposure differ, and obstetric injections have their own monitored uses.
Sources Labels, studies and notes behind this guide
Catalog evidence: Other human research. This describes the type of evidence, not a clinical review of every claim.
Summary and fact source checks: 2026-10-07. This records source checking, not medical review of the whole page.
Notes on the quick facts
- Common interest
- A popular reason for searching; a benefit is not established.
- Trial result
- Both groups improved in the named study.
- 1. DailyMed: PITOCIN prescribing information
May 2026 label: medically indicated obstetric uses, IV infusion or IM depending on indication; plasma half-life 1–6 min, uterine response after IM can last 2–3 h.
- 2. Muin et al.: intranasal oxytocin sexual-function trial
Randomized crossover study in women with sexual dysfunction; 32 IU intranasal study context; both treatment and placebo improved without treatment-group superiority.
- 3. PITOCIN label, Clinical Pharmacology
PITOCIN is an IV infusion/IM activity-unit product. Plasma half-life is 1–6 min; the 2–3 h uterine response after IM dosing is a duration of effect, not plasma half-life.
Related compounds and examples
Related compounds
PT-141 (Bremelanotide)
PT-141 is researched for low sexual desire. As VYLEESI, bremelanotide is an on-demand treatment for acquired, generalized low desire causing distress in premenopausal women. It is not a general performance enhancer, and nausea is a common trade-off.
Alprostadil (PGE1)
Alprostadil is an erection treatment that acts locally to increase blood flow. It can be useful when a clinician chooses injection therapy, but finding the right dose and learning the technique matter: pain and prolonged erections are important trade-offs.
Melanotan I (Afamelanotide)
Melanotan I attracts people who want a darker tan. Its medicine form, afamelanotide, is used for a rare light-sensitivity disorder; the approved implant is very different from tanning powders sold online. A tan does not replace sun protection.